These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22610724)

  • 21. Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia.
    Climent E; Pérez-Calahorra S; Marco-Benedí V; Plana N; Sánchez R; Ros E; Ascaso JF; Puzo J; Almagro F; Lahoz C; Civeira F; Pedro-Botet J
    Sci Rep; 2017 Jul; 7(1):5596. PubMed ID: 28717233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease.
    Yuan G; Wang J; Hegele RA
    CMAJ; 2006 Apr; 174(8):1124-9. PubMed ID: 16606962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing the Detection and Care of Heterozygous Familial Hypercholesterolemia in Primary Care: Cost-Effectiveness and Return on Investment.
    Marquina C; Morton J; Brett T; Lloyd M; Radford J; Heal C; Hespe C; Gill G; Sullivan D; Zomer E; Li I; Pang J; Watts GF; Ademi Z
    Circ Genom Precis Med; 2023 Jun; 16(3):267-274. PubMed ID: 37042242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
    Fouchier SW; Kastelein JJ; Defesche JC
    Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization.
    Descamps OS; Tenoutasse S; Stephenne X; Gies I; Beauloye V; Lebrethon MC; De Beaufort C; De Waele K; Scheen A; Rietzschel E; Mangano A; Panier JP; Ducobu J; Langlois M; Balligand JL; Legat P; Blaton V; Muls E; Van Gaal L; Sokal E; Rooman R; Carpentier Y; De Backer G; Heller FR
    Atherosclerosis; 2011 Oct; 218(2):272-80. PubMed ID: 21762914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece.
    Diakou M; Miltiadous G; Xenophontos SL; Manoli P; Cariolou MA; Elisaf M
    Eur J Intern Med; 2011 Oct; 22(5):e55-9. PubMed ID: 21925044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Inclisiran in Patients Having Familial Hypercholesterolemia: Heterozygous Compared to Homozygous Trait, a Systematic Review and Meta-analysis.
    Rai R; Devi P; Kumar K; Naeem K; Kumar H; Kumari K; Kumar A; Kumar A; Muhammad A; Khan MS; Qadir G; Ali S; Maheshwari M; Jawwad M
    Crit Pathw Cardiol; 2024 Jun; 23(2):73-80. PubMed ID: 38446086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial hypercholesterolemia: epidemiology, Neolithic origins and modern geographic distribution.
    Liyanage KE; Burnett JR; Hooper AJ; van Bockxmeer FM
    Crit Rev Clin Lab Sci; 2011; 48(1):1-18. PubMed ID: 21657943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening.
    Leren TP; Finborud TH; Manshaus TE; Ose L; Berge KE
    Community Genet; 2008; 11(1):26-35. PubMed ID: 18196915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial hypercholesterolemia/autosomal dominant hypercholesterolemia: Molecular defects, the LDL-C continuum, and gradients of phenotypic severity.
    Foody JM; Vishwanath R
    J Clin Lipidol; 2016; 10(4):970-986. PubMed ID: 27578130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic children.
    van der Graaf A; Avis HJ; Kusters DM; Vissers MN; Hutten BA; Defesche JC; Huijgen R; Fouchier SW; Wijburg FA; Kastelein JJ; Wiegman A
    Circulation; 2011 Mar; 123(11):1167-73. PubMed ID: 21382890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cascade genetic screening for familial hypercholesterolemia.
    Leren TP
    Clin Genet; 2004 Dec; 66(6):483-7. PubMed ID: 15521974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients.
    Pérez-Calahorra S; Sánchez-Hernández RM; Plana N; Marco-Benedi V; Pedro-Botet J; Almagro F; Brea A; Ascaso JF; Lahoz C; Civeira F;
    Am J Cardiol; 2017 Mar; 119(5):742-748. PubMed ID: 28081939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are patients with familial hypercholesterolaemia well managed in lipid clinics? An audit of eleven clinics from the Department of Health Familial Hypercholesterolaemia Cascade Testing project.
    Hadfield SG; Horara S; Starr BJ; Yazdgerdi S; Bhatnagar D; Cramb R; Egan S; Everdell R; Ferns G; Jones A; Marenah CB; Marples J; Prinsloo P; Sneyd A; Stewart MF; Sandle L; Wang T; Watson MS; Humphries SE
    Ann Clin Biochem; 2008 Mar; 45(Pt 2):199-205. PubMed ID: 18325186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary computed tomographic angiographic findings in asymptomatic patients with heterozygous familial hypercholesterolemia and null allele low-density lipoprotein receptor mutations.
    Viladés Medel D; Leta Petracca R; Carreras Costa F; Cardona Olle M; Barros Membrilla A; Hidalgo Perez JA; Pujadas Olano S; Alomar Serrallach X; Franco Peral M; Pons-Lladó G
    Am J Cardiol; 2013 Apr; 111(7):955-61. PubMed ID: 23340035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Awareness, diagnosis and treatment of heterozygous familial hypercholesterolemia (HeFH) - Results of a US national survey.
    Block RC; Bang M; Peterson A; Wong ND; Karalis DG
    J Clin Lipidol; 2021; 15(5):682-689. PubMed ID: 34593357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opportunistic screening for familial hypercholesterolaemia via a community laboratory.
    Bell DA; Hooper AJ; Bender R; McMahon J; Edwards G; van Bockxmeer FM; Watts GF; Burnett JR
    Ann Clin Biochem; 2012 Nov; 49(Pt 6):534-7. PubMed ID: 23002132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of heterozygous familial hypercholesterolemia and combined hyperlipidemia phenotype in very young survivors of myocardial infarction and their association with the severity of atheromatous burden.
    Rallidis LS; Kosmas N; Tsirebolos G; Rallidi M; Kiouri E; Kalpakos D
    J Clin Lipidol; 2019; 13(3):502-508. PubMed ID: 30956097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.